A newly released rapid communication from the WHO outlines its upcoming comprehensive new guideline on balanced national policies for controlled medicines, a strategy the agency hopes will lead to better access of controlled substances needed for pain treatment and management across the globe.
The guideline’s recommendations, officially presented at the 2025 World Health Assembly, “are designed to support countries in ensuring safe, equitable and affordable access to essential